Skip to main navigation Skip to search Skip to main content

King Fahd University of Petroleum & Minerals Home

Help & FAQ Link opens in a new tab

Search content at King Fahd University of Petroleum & Minerals

Home
Profiles
Research units
Projects
Research output
Prizes
Student theses

GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION

Anvar Isab (Inventor)

King Fahd University of Petroleum & Minerals
Interdisciplinary Research Center for Advanced Materials
Department of Chemistry

Research output: Patent

Overview

Original language	English
Patent number	US9880170
State	Published - 2018

Cite this

APA
Author
BIBTEX
Harvard
Standard
RIS
Vancouver

Isab, A. (2018). GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION. (Patent No. US9880170).

Isab, Anvar (Inventor). / GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION. Patent No.: US9880170.

@misc{bd3c850ab2b24844883176d4b3cd889b,

title = "GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION",

author = "Anvar Isab",

year = "2018",

language = "English",

type = "Patent",

note = "US9880170",

}

Isab, A, GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION, Patent No. US9880170.

GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION. / Isab, Anvar (Inventor).
Patent No.: US9880170.

Research output: Patent

TY - PAT

T1 - GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION

AU - Isab, Anvar

PY - 2018

Y1 - 2018

M3 - Patent

M1 - US9880170

ER -

Isab A, inventor. GLUTHATIONE / GOLD(III) PHARMACEUTICAL COMPOSITION. US9880170. 2018.

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 King Fahd University of Petroleum & Minerals, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure Link opens in a new tab

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab